Thursday, January 26, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Funding News

RFP – Clinical Research Services Sought by NIH Vaccine Research Center

by Global Biodefense Staff
December 9, 2016
Vaccine Clinical Trial Research

Vaccine Clinical Trial ResearchThe Dale and Betty Bumpers Vaccine Research Center (VRC) at the National Institutes of Health (NIH) is soliciting for clinical research support services under a new Request for Proposals (RFP) issued this week.

The VRC is dedicated to improving global human health through the rigorous pursuit of effective vaccines for human diseases including HIV, diseases identified as biodefense concerns, and emerging/re-emerging infectious diseases.

The Clinical Trials Program within the VRC implements human clinical research trials; conducting Phase I/II/IIb trials of candidate vaccines and/or other immune modulators for infectious diseases such as HIV, Influenza, Ebola, Zika, Malaria, and Chikungunya.

In addition, the VRC operates the National Institute of Allergy and Infectious Diseases (NIAID) Vaccine Immune T-Cell and Antibody Laboratory (NVITAL) which provides state-of-the-art immunogenicity testing, critically important for evaluation of clinical research specimens.

The selected contractor will coordinate clinical monitoring activities and complete all necessary clinical trial activities to support the VRC’s research efforts and enable the VRC to rapidly establish collaborations with academic institutions and health research organizations in response to the urgent research demands of global importance.

This Indefinite Delivery, Indefinite Quantity (IDIQ) contract will allow the VRC, as well as other components of the NIH, to support translational and clinical research through clinical trial site activation and activities to monitor rights and safety of human subjects, investigator adherence to the protocol, regulations and guidelines and integrity of data and recording processes.

Further details are available via Solicitation Number: NIHAO2017058. Questions regarding the opportunity must be submitted no later than Wednesday December 14, 2016. The RFP response deadline is February 16, 2017.

Tags: ChikungunyaEbolaHIVInfluenzaMalariaRequest for ProposalsVaccinesZika

Related Posts

Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA
Funding News

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
DARPA Selects Teams to Develop Vaccine Durability Prediction Model
Medical Countermeasures

DARPA Selects Teams to Develop Vaccine Durability Prediction Model

January 13, 2023
small glass vials on an assembly line await filling of vaccine solution
Industry News

Sabin Vaccine Institute to Advance Ebola Sudan and Marburg Vaccines with New BARDA Funding

January 12, 2023
How Are Bivalent COVID Vaccines Stacking Up Against Omicron?
Infectious Diseases

How Are Bivalent COVID Vaccines Stacking Up Against Omicron?

January 12, 2023
Load More

Latest News

Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023
Biodefense Headlines – 24 January 2023

Biodefense Headlines – 24 January 2023

January 24, 2023
Biodefense Headlines – 17 January 2023

Biodefense Headlines – 17 January 2023

January 17, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC